# MedGenics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/medgenics

- Industry: Biotechnology
- Headquarters: Wayne, US
- Website: www.medgenics.com
- Total disclosed funding: $15M
- Latest round: Series B (May 12, 2003)
- Investors on record: 4

## About

MedGenics, Inc. focuses on developing innovative technologies to improve operational efficiency across various industries, providing tailored software solutions for workflow management and data analytics.MedGenics, Inc. specializes in operational efficiency solutions, offering a suite of software applications designed for various sectors. The company is headquartered in Wayne, US. It has attracted a total investment of USD 3.20 mn through multiple funding rounds, with the most recent deal occurring on December 2, 2007, when it raised GBP 3.3 mn in an IPO on the London AIM.The company delivers a comprehensive range of software solutions aimed at enhancing workflow management, data analytics, and customer relationship management, particularly for small to medium-sized enterprises in retail, healthcare, and logistics. Its cloud-based technology allows clients to access solutions remotely, facilitating real-time collaboration in key markets like North America and Western Europe.MedGenics, Inc. generates revenue through a subscription-based model, enabling clients to access its software applications continuously. The annual agreements ensure clients benefit from ongoing updates and support, with pricing based on user numbers and selected modules, fostering customer loyalty and predictable revenue streams. The company's EBITDA for the most recent year, 2018, was -USD 30.90 mn.Looking ahead, MedGenics, Inc. aims to introduce new products designed to enhance its software offerings, with specific release dates yet to be determined. The company is also targeting expansion into emerging markets in Asia and Latin America by the end of 2025. The funds raised in December 2007 will support these initiatives by facilitating product development and market entry strategies.

## Funding rounds

- Series B, May 12, 2003, $7.5M — Aurum Ventures
- Series A, Jun 20, 2001, $7M — Alta Berkeley, Alta Partners, Koor Corporate Venture Capital

## Investors

- Alta Berkeley (https://capitalatlas.ai/funds/alta-berkeley) — Series A
- Alta Partners (https://capitalatlas.ai/funds/alta-partners) — Series A
- Koor Corporate Venture Capital (https://capitalatlas.ai/funds/koor-corporate-venture-capital) — Series A
- Aurum Ventures (https://capitalatlas.ai/funds/aurum-ventures) — Series B